Unlock stock picks and a broker-level newsfeed that powers Wall Street.

25 Most Health-Conscious Cities in the US

In This Article:

In this article, we will be taking a look at the 25 most health-conscious cities in the U.S. If you wish to see the top ones, head straight to the 5 Most Health-Conscious Cities in the U.S.

Obesity—a medical condition in which a person has a Body Mass Index (BMI) of 30 or more—is influenced by a wide range of factors, including overeating, lack of physical activity, metabolism, genetics, culture, and poor dietary choices. Some of the serious health consequences of carrying extra fat include osteoarthritis, type 2 diabetes, cardiovascular disease, and some types of cancer.

The prevalence of obesity is a significant health concern in the United States. According to information gathered by the Centres for Disease Control and Prevention (CDC) between 2017 and 2020, 41.9% of adults in the country have obesity. Moreover, the annual cost of obesity to the US healthcare system is close to $173 billion.

The obesity treatment market is assisting obese people in achieving and maintaining a healthy weight and reducing the likelihood of developing obesity-related problems. According to a report by Market Research Future, the obesity treatment market was valued at $10.8 billion in 2022. The market is anticipated to grow from $12.6 billion in 2023 and expand at a compound annual growth rate of 16.8% from 2023 to 2032, reaching a value of $32.3 billion at the conclusion of the predicted period. The key factors influencing the market's expansion are poor eating habits and inactive lifestyles. Per the report, the obesity treatment market in North America, which had a market value of $4.94 billion in 2022, is anticipated to experience the fastest growth throughout the forecasted period.

A December 2022 Gallup Panel survey of 1,803 adults aged 18 and older revealed that 7 in 10 Americans planned to establish goals for 2023, and a whopping 80% of those goal-setters intended to adopt personal health or fitness goals.

Moreover, we previously reported that a survey conducted by Nutrisystem and OnePoll in September 2022 found that more than 70% of Americans were now more health-conscious post the COVID-19 pandemic. More than 60% of the respondents were inspired to lose weight after learning how their weight affected their immunity.

Meanwhile, medicines to treat obesity are all the rage these days, and a recent survey from KFF found that almost half of Americans adults (45%) expressed interest in using safe and effective prescription weight loss drugs like Ozempic, Wegovy, and Mounjaro.

Novo Nordisk A/S (NYSE:NVO), a multinational pharmaceutical company based in Bagsvaerd, Denmark, is the maker of Ozempic and Wegovy. Both drugs contain the same active component, semaglutide. However, only Wegovy has the US Food and Drug Administration (FDA) approval for the treatment of obesity since it contains a higher dose of semaglutide (2.4mg). As of August 28, the stock has returned 36.12% to investors on a year-to-date basis.